Loss of heterozygosity in normal tissue adjacent to breast carcinomas.
about
Identification of AXUD1, a novel human gene induced by AXIN1 and its reduced expression in human carcinomas of the lung, liver, colon and kidneyFibronectin expression modulates mammary epithelial cell proliferation during acinar differentiationMultistep tumorigenesis and the microenvironmentAllelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progressionMutations in normal breast tissue and breast tumoursMammary cancer and epithelial stem cells: a problem or a solution?The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesionsHost microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breastThe diagnosis and management of pre-invasive breast disease: another point of viewM6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosisp16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells.Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast CancerConsiderations for accurate gene expression measurement by reverse transcription quantitative PCR when analysing clinical samplesThe Potentials and Pitfalls of Microarrays in Neglected Tropical Diseases: A Focus on Human Filarial InfectionsMMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathwaysPutting tumours in contextHigh-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele lossBiallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancerChromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features.Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancerThe biological sense of cancer: a hypothesisOf extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer.Tumors as organs: complex tissues that interface with the entire organismSpontaneous slow replication fork progression elicits mitosis alterations in homologous recombination-deficient mammalian cells.Selective regain of egfr gene copies in CD44+/CD24-/low breast cancer cellular model MDA-MB-468.A tumor-specific kinase activity regulates the viral death protein Apoptin.Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features.Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis.Gene expression profiles of human breast cancer progression.Isolation and characterization of human mammary stem cells.Gene expression signatures of morphologically normal breast tissue identify basal-like tumorsClinical implications and utility of field cancerizationGenomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization.Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypesPhenotypic and functional characterization of human mammary stem/progenitor cells in long term culture.The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: a unique resource for defining the "molecular histology" of the breast.Molecular prognostic markers in breast cancer.Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patientsDNA demethylation in normal colon tissue predicts predisposition to multiple cancers.In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer.
P2860
Q24291619-7E1A7919-0B3F-4E30-9DD4-3103300A532CQ24649457-CBC93E33-142F-4B82-AE64-E8B8F1ED0EF5Q24794552-BE3F18CF-698E-4E4C-A51E-1302D77BC296Q24796515-7AE46BF1-BC19-4D7F-9A8F-F37863A129F1Q24801662-7A6E23B2-3854-40E7-82F6-0E79B0E268EBQ24802179-F7F82B05-BC6B-4F95-8CD3-702986DA6541Q24802857-CAE8B8BB-D718-4488-A2F4-5699DE44DA80Q24803379-CD72679D-9C70-4EE5-A295-C303056FF46DQ24803959-A2642C01-717F-4F74-B5E7-AA901C722E4AQ24805128-5AD26AF1-5F49-492E-AA6B-B9E35AB128E6Q25255634-B26A3E91-1005-41A3-994A-564B10250F04Q26738987-AC768FD8-4B36-47EA-AD66-53C4C575E802Q26863503-37615E13-7258-486E-AF84-D80DCB2A1C26Q28079948-70CE73E3-1796-468B-AA3E-08C03A314DC3Q28138383-94D7A8F3-7F2E-4642-B804-AC67F5DCB2BBQ28207789-4A1D041F-6D89-46AE-BD79-D292AD24C184Q28343524-6A3C88D6-73DA-4C2C-8037-A52149B3864DQ28345689-6581353B-C5F1-4561-ACCB-DB5CFAA0E50FQ28360494-FF0B4A3E-F23D-4E45-8BC1-0D70028EA518Q28389284-C032D5CF-D4FE-4998-AB97-7678CA0C712CQ28763945-468E1511-BC63-4FC3-80FE-1EBBAF96925EQ30355361-45F44AAE-AF13-45DB-987D-99736A22288EQ30495528-0B43EC5B-1300-4FCD-9418-61ED0BA405E9Q30565967-312B8DEE-8F90-4B95-8DD0-8694391A5957Q30978860-1FCACBFB-D248-432C-B788-2B5824006CF6Q31115267-357B3499-CF31-4775-B9FB-022918745640Q31122061-1B0CE09B-6980-4636-A458-51E217E7E056Q31920335-E6562132-BB88-435D-B827-8F35EC2B02C5Q33186821-E16430A0-7EE1-4505-A4CE-165E433F0E60Q33227579-0F2AF193-01EF-4454-B51F-80F2940D5E64Q33261032-73702DA2-5915-4AB2-AAE3-4F822C403871Q33278836-16CE365D-C4C2-4F75-B1EF-D54F059DFD6DQ33289495-763B0A1F-F051-4A49-AFEC-813AD52BAA5EQ33403396-20A8BE4C-EF78-409D-A221-C12209A0C6E4Q33434483-D2E269CC-69F3-403D-B394-EEFB9D22BFD2Q33454487-6467684A-177E-4B5E-92B4-BA34217556BDQ33538447-C20FA36A-5558-4618-A60F-2E9180994D20Q33540332-5BA30EE0-67B8-49E3-8BEE-34CAC7AE779AQ33581249-3186ABBA-D643-442B-A79A-039CA55A3E47Q33605281-D79EA208-DE2C-4B1A-AF4A-5866A35EA1E5
P2860
Loss of heterozygosity in normal tissue adjacent to breast carcinomas.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Loss of heterozygosity in normal tissue adjacent to breast carcinomas.
@en
Loss of heterozygosity in normal tissue adjacent to breast carcinomas.
@nl
type
label
Loss of heterozygosity in normal tissue adjacent to breast carcinomas.
@en
Loss of heterozygosity in normal tissue adjacent to breast carcinomas.
@nl
prefLabel
Loss of heterozygosity in normal tissue adjacent to breast carcinomas.
@en
Loss of heterozygosity in normal tissue adjacent to breast carcinomas.
@nl
P2093
P1433
P1476
Loss of heterozygosity in normal tissue adjacent to breast carcinomas.
@en
P2093
P304
P356
10.1126/SCIENCE.274.5295.2057
P407
P577
1996-12-01T00:00:00Z